Everything You Need to Know About Fragile X for Step 1

Fragile X syndrome is one of those “classic genetics” topics that shows up everywhere on Step 1: trinucleotide repeats, X-linked inheritance patterns, intellectual disability, autism spectrum features, and that unmistakable phenotype (big ears + long face + macroorchidism). If you can connect the gene-level mechanism to the clinical picture and testing, you’ll pick up a lot of easy points.

---

What Is Fragile X Syndrome?

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and a major genetic cause of autism spectrum disorder. It’s due to a trinucleotide repeat expansion in the FMR1 gene on the X chromosome.

Core idea:

• CGG repeat expansion in FMR1 → gene silencing → ↓ FMRP (Fragile X mental retardation protein) → abnormal synaptic development/plasticity → neurodevelopmental phenotype.

---

Genetics & Pathophysiology (The Mechanism Step 1 Loves)

The Mutation

• Gene: FMR1
• Chromosome: X
• Repeat: CGG
• Type of mutation: Dynamic mutation (repeat expansion), leading to anticipation

Full Mutation vs Premutation (High-Yield Distinction)

Why the Phenotype Happens

FMRP helps regulate translation of synaptic proteins (especially at dendritic spines).
Loss of FMRP → abnormal dendritic spine morphology (often described as long/thin/immature) → impaired synaptic plasticity → learning and behavioral symptoms.

Anticipation & Maternal Transmission

• Fragile X shows anticipation (worsening severity / earlier onset in successive generations) due to repeat expansion during gametogenesis.
• Key Step 1 nuance: Expansion to full mutation is more likely during oogenesis, so transmission risk is classically emphasized through maternal carriers.

---

Inheritance Pattern: How It Presents on Pedigrees

Fragile X is X-linked dominant with variable penetrance and variable expressivity.

Testable pedigree clues

• No male-to-male transmission (because dads give sons a Y chromosome).
• Males are typically more severely affected (only one X).
• Female carriers can be symptomatic (due to X-inactivation skewing), often with milder cognitive/psychiatric findings.

---

Clinical Presentation (What to Recognize in a Vignette)

Neurodevelopmental/Behavioral

• Intellectual disability (often more severe in males)
• Autism spectrum disorder features
• ADHD, anxiety, social avoidance
• Language delay; learning difficulties

Characteristic Physical Features (Classic Board-Style)

• Long, narrow face
• Large, protruding ears
• Macroorchidism (postpubertal males)
• High-arched palate
• Hyperextensible joints
• Mitral valve prolapse (connective tissue–type finding)

When Features Become Obvious

• Many physical traits become more apparent with age; macroorchidism is typically noted after puberty.

---

Diagnosis (What Test Confirms It?)

Best Diagnostic Test

• DNA-based testing for CGG repeat number and methylation status:
  • PCR (good for sizing smaller expansions)
  • Southern blot (historically used; helps detect large expansions and methylation status—still conceptually testable)

Why karyotype isn’t enough:
The “fragile site” on X chromosome can be suggested cytogenetically, but modern diagnosis is by molecular testing.

What You Might See in the Stem (Clinical Clues)

• Male child with developmental delay + autistic behaviors + large ears/long face
• Family history of “learning problems” in maternal relatives
• Adult male relative with late-onset tremor/ataxia (points to premutation)

---

Treatment & Management (Step-Relevant)

There is no cure that reverses the genetic defect, so management is supportive and multidisciplinary:

• Early intervention: speech/language therapy, occupational therapy, individualized education plans
• Behavioral therapy for ASD/ADHD features
• Medications (symptom-targeted):
  • Stimulants for ADHD
  • SSRIs for anxiety
  • Antipsychotics in select cases for severe irritability/aggression
• Genetic counseling:
  • Carrier testing for family members
  • Discussion of premutation/full mutation risks and anticipation

---

High-Yield Associations & Test Traps

1) Premutation Syndromes (Very Testable)

Premutation carriers (especially older adults and some women) can have distinct disorders due to toxic gain-of-function from increased FMR1 mRNA:

• FXTAS (Fragile X–associated tremor/ataxia syndrome)

  • Typically older males
  • Intention tremor, ataxia, parkinsonism-like features, cognitive decline

• FXPOI (Fragile X–associated primary ovarian insufficiency)

  • In some female premutation carriers
  • Infertility, irregular menses, early menopause

2) Fragile X vs Rett vs Angelman (Don’t Mix Them Up)

A fast discriminator table:

3) “Autism + Macroorchidism” is a giveaway

If the question pairs ASD features with macroorchidism, think Fragile X first.

4) Connective tissue findings

Fragile X can show MVP and joint hypermobility—often used to tempt you toward Marfan/Ehlers-Danlos, but the neurodevelopmental phenotype and X-linked repeat expansion are the anchors.

---

First Aid Cross-References (Where This Lives in Your Head)

Use these as mental bookmarks rather than page numbers (since editions vary):

• Genetics → Trinucleotide repeat disorders
  • Fragile X: CGG repeat, X-linked, anticipation
  • Contrast with:
    • Huntington: CAG
    • Myotonic dystrophy: CTG
    • Friedreich ataxia: GAA
• Neurodevelopmental disorders
  • Intellectual disability, ASD associations
• Reproductive/endocrine associations
  • Premutation → FXPOI
• Neurology (movement disorders in older adults)
  • Premutation → FXTAS

---

Rapid-Fire Step 1 Review (High-Yield Checklist)

• Most common inherited cause of intellectual disability
• FMR1 on X chromosome
• CGG repeat expansion
• >200 repeats → hypermethylation → silenced gene → ↓ FMRP
• Anticipation, especially with maternal transmission
• Classic phenotype: long face, large ears, macroorchidism
• Behavioral: ASD, ADHD, anxiety
• Confirm with PCR/Southern blot repeat sizing (molecular testing)
• Premutation complications:
  • FXTAS (older males: tremor/ataxia)
  • FXPOI (female ovarian insufficiency)